User
Information for Reviewer
Index

JKB telah terindex di Crossref JKB telah terindex di Google Scholar JKB telah terindex di SINTA Ristekdikti JKB telah terindex di Portal Garuda

Notifications
Journal Content

Browse

AKTIVASI SPONTAN SEL T LIMFOSIT MENCIT YANG MENGALAMI DEFISIENSI IL2Rβ

Agustina Tri Endharti
  Jurnal Kedokteran Brawijaya, Vol 23, No 1 (2007),  pp.40-46  

Abstract


Homologous recombination applied to alter specific  endogenous gene, referred as gene targeting, provides the highest level of control over product mutation in cloned genes. In this experiment we showed that by using gene targeting a knock out mutation in IL-2Rβ gene could be generated. The findings of this study indicated that mice lacking the Interleukin-2 receptor β chain (IL2Rβ-/-) had spontaneously activated.T cells. In this study, we investigated abnormal expansion of activated T cells which showed high level of CD69.  These findings suggest that the IL2Rβ-/- mice may serve as animal model for autoimmune diseases and that the accumulation of activated T cell in the future could be usedin clinical setting to cure the diseases. Keywords:T cells, (IL2Rβ-/-), autoimmune

Full Text:

PDF

References


Paul WE and Selder RA. Lymphocyte responses and cytokine. Cell 1998; 78: 241-244.

Theze J, Alzari PM and Bertogilo J. IL-2 and it`s Receptor Recent Advance and New Immunological Functions. Immunol Today 1996; 17: 481-486.

Willerford PM, Chem J, Ferry JA, Davidson L and AltFW. IL-2 Receptor A Chain Regulates the Size and Content of the Peripheral Lymphoid Compartment. Immunity 1995; 3: 521-523.

Boise LH and Thomson CB. Hierarchical Control of Lymphocytes Survival. Science 1998; 275: 67-68.

Bamford RN and Asao H. Interleukin (IL) 2 Receptor Beta Chain is Shared byIL-2 and Cytokine that Stimulated T Cell Proliferation. USA: Proc Natl Acad Sci; 1998; 92: 4542-4545.

Salustro F, Lenig D, Forster R, Lipp M and Lanzavecchia A. Two Subsets of Memory T Lymphocyte with Distinct Homimg Potential and Effector Functions. Nature 1999;401:708-712.

Taniguchi T and Minami Y. The IL-2/IL-2 Receptor System: a Current Overview. Cell 1994; 73: 5-8.

Theze J, Alzari PM and Bertoglio J. Interleukin-2 and its Receptor: Recent Advances andNew Immunological Function. Immunol Today 2000;10:90-96.

Nelson BH and Willerford DM. Biology of the Interleukin-2 Receptor. Adv. Immunol 1997;70:1-8.

Waldman TA, Dubois S and Tagaya Y. Roles of Interleukin 2 in the Life and Death of Lymphocytes. Immunity 2001;14:105-110.

Rafaeli Y, Van Parjis L, London CA and Tschopp J. Biochemical Mechanisms of IL-2 Regulated Fas Mediated T cell Apoptosis.Immunity 1998;8:616-623

Grabstein KH, Eisenman K, Shanebeck C, Rauch S, Srinivasan V, Fung C, Beers J, Richardson MA and Schoenborn M. Cloning of a T Cells Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor.Science 1994; 264-265.

Ascherman DP, Migone TS, Friedmann MC and Leonard WJ. Interleukin-2 (IL-2) Mediated Induction of the IL-2 Receptor αChain Gene.J. Biol. Chem 1997;272:8704-8709.

Minami Y, Kono T, Miyazaki T and Taniguchi T. The IL-2 Receptor Complex: its Structure, Function and Target Genes. Annu. Rev. Immunol 1999;11:254-268.

Minami Y, Kono T, Miyazaki T and Taniguchi T. The IL-2 Receptor Complex: its Structure, Function and Target Genes. Annu. Rev. Immunnol 1996;11:245-268.

Joiner AL. Gene Targeting. Oxford University Press 2000;133-166.

Van Parjis L, Biuckians A, Ibraghimov A, Alt FW and Willerford D. Functional Responses in IL-2 Receptor Alpha Deficient Lymphocytes Expressing a Transgenic Antigen Receptor.Immunol 1997;158:3738-3745.

Castigli E, Pahwa R, Good RA, Geha RS and Chatila TA. Molecular Basis of Multiple Lymphokine Deficiency in Patient with Severe Combined Immunodeficiency. USA:Proc.Natl. Acad. Sci 1993;90:4728-4732.

Disanto JP, Keever CA, Small TN, Nicolas GR, O`RellyRJ, and Flomenberg N. Absence of Interleukin-2 Production in a with Severe Combined Immuno-Deficiency Disease Syndrome with T Cells. J. Exp. Med. 1990;171:1697-1704.

Waldman TA. The IL-2/IL-2 Receptor System: a Target for Rational Immune Intervention.Immunol. Today 2000;14:264-270.

Schimpl A, Hunig A, Elbe I, Berberich S, Kramer H, Merz AC, Feller B, Sadlack H, Schoele and Horak I. Development and Function of Immune System in Mice with Targeted Disruption of the IL-2 Gene. Transgenic and Targeted Mutagenesis in Immunology. London: Academic Press. 2000;191-201.

Asano M, Toda M, Sakaguchi N and Sakaguchi S. Autoimmune Disease as a Consequence of Developmental Abnormality of a T Cell Subpopulation.J. Exp. Med. 1996;184:387-396.

Sadlack BR, Kuhn H, Rajewsky, W, Muler J and Horak I. Development and Proliferation of Lymphocyte In Mice Deficient for IL-2.Eur. J. Immunol.24:281-284.




DOI: http://dx.doi.org/10.21776/ub.jkb.2007.023.01.7

Refbacks

  • There are currently no refbacks.